Literature DB >> 26498858

Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways.

Stephen P Duggan1, Justin V McCarthy2.   

Abstract

The presenilins are the catalytic subunit of the membrane-embedded tetrameric γ-secretase protease complexes. More that 90 transmembrane proteins have been reported to be γ-secretase substrates, including the widely studied amyloid precursor protein (APP) and the Notch receptor, which are precursors for the generation of amyloid-β peptides and biologically active APP intracellular domain (AICD) and Notch intracellular domain (NICD). The diversity of γ-secretase substrates highlights the importance of presenilin-dependent γ-secretase protease activities as a regulatory mechanism in a range of biological systems. However, there is also a growing body of evidence that supports the existence of γ-secretase-independent functions for the presenilins in the regulation and progression of an array of cell signalling pathways. In this review, we will present an overview of current literature that proposes evolutionarily conserved presenilin functions outside of the γ-secretase complex, with a focus on the suggested role of the presenilins in the regulation of Wnt/β-catenin signalling, protein trafficking and degradation, calcium homeostasis and apoptosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Apoptosis; Autophagy; Calcium homeostasis; Presenilin; Protein trafficking; Wnt signalling; γ-Secretase

Mesh:

Substances:

Year:  2015        PMID: 26498858     DOI: 10.1016/j.cellsig.2015.10.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  41 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

Review 2.  Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.

Authors:  Ralph A Nixon
Journal:  FASEB J       Date:  2017-07       Impact factor: 5.191

Review 3.  Notch in skeletal physiology and disease.

Authors:  E Canalis
Journal:  Osteoporos Int       Date:  2018-09-07       Impact factor: 4.507

4.  PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2+ homeostasis.

Authors:  Chiara Fedeli; Riccardo Filadi; Alice Rossi; Cristina Mammucari; Paola Pizzo
Journal:  Autophagy       Date:  2019-03-27       Impact factor: 16.016

Review 5.  Notch Signaling and the Skeleton.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2016-04-13       Impact factor: 19.871

Review 6.  Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?

Authors:  Elena Popugaeva; Ekaterina Pchitskaya; Ilya Bezprozvanny
Journal:  Biochem Biophys Res Commun       Date:  2016-09-15       Impact factor: 3.575

Review 7.  Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.

Authors:  Ernesto Canalis
Journal:  Metabolism       Date:  2017-08-24       Impact factor: 8.694

8.  An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice.

Authors:  Jungeun Yu; Christian W Siebel; Lauren Schilling; Ernesto Canalis
Journal:  J Cell Physiol       Date:  2019-06-12       Impact factor: 6.384

Review 9.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

10.  The Hajdu Cheney Mutation Is a Determinant of B-Cell Allocation of the Splenic Marginal Zone.

Authors:  Jungeun Yu; Stefano Zanotti; Bhavita Walia; Evan Jellison; Archana Sanjay; Ernesto Canalis
Journal:  Am J Pathol       Date:  2017-10-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.